Skip to Main Content

About me

He | Him | His

Dr. Steven Seyedin is a radiation oncologist who cares for patients with genitourinary cancers (those of the reproductive and urinary systems). His treatment expertise includes prostate, kidney, bladder and testicular cancer.

His research focuses on integrating advanced technologies, such as stereotactic body radiation therapy (which allows precise delivery of high radiation doses), with other targeted therapies in order to improve patients' chances of beating genitourinary cancers. He enjoys collaborating with other UCSF researchers to usher new treatments from the laboratory to the clinic and offering his patients clinical trials with cutting-edge treatment. His work has been published in JAMA Oncology, Frontiers in Oncology, and the International Journal of Radiation Oncology, Biology, and Physics.

He earned his medical degree at the David Geffen School of Medicine at UCLA. He completed a residency in radiation oncology at the University of Iowa.

While he is a San Francisco Bay Area native, he has lived in five states over the past 15 years and was thrilled to come back home to provide care to his community. When he isn't in the clinic or at his office conducting research, he can often be found on a tennis court or spending time with his nephews.

  • Board Certifications

    American Board of Radiology, Radiation Oncology, 2021

  • Residencies

    University of Iowa Hospital and Clinics, Radiation Oncology, 2020

  • Internship

    University of Illinois College of Medicine, Internal Medicine, 2016

  • Education

    University of California, Los Angeles David Geffen School of Medicine, 2014

  • Languages

    English

I envision care as a ship at sea with the patient as the captain and myself as first mate, helping them navigate uncharted waters.

Where I see patients (1)

    My reviews

    5.0

    Overall Experience
    60 Ratings
    About our process
    Mar 14, 2025
    pleasant
    Feb 07, 2025
    Great doctor
    Jan 24, 2025
    I would recommend this care provider to any who requires health care.
    Dec 21, 2024
    I talk UCSF up every chance I get
    Dec 05, 2024
    Outstanding doctor; impressive
    Dec 03, 2024
    Dr. Seyedin was an excellent provider of information, options, and he listened and responded very well. I had great rapport with him and would highly recommend him.
    Nov 27, 2024
    Dr. Seyedin is an excellent doctor. Very upbeat and positive thinker.
    Nov 23, 2024
    Very caring of my concern
    Nov 05, 2024
    Doctor was very helpful
    Oct 24, 2024
    My new Doctor there is a vary caring person that I got from him. I'm happy to be seen by him.
    Oct 21, 2024
    Very good.
    Oct 19, 2024
    Very happy with the treatment that was extended to me and my family thank you.
    Oct 17, 2024
    Dr. Seyedin offers outstanding care!
    Oct 09, 2024
    Dr was amazing
    Sep 28, 2024
    Dr. Seyedin is very professional, courteous and informal.
    Sep 20, 2024
    Impressed with knowledge, competence ,confidence and thoroughness of the doctor. Made me have confidence in him.
    Aug 27, 2024
    The Doctor is a very friendly person and it was easy to ask him questions which he answered without any problems
    Aug 22, 2024
    Excellent and caring doctor. This has been my experience with all UCSF staff so far.
    Aug 06, 2024
    I was very impressed with Dr Seyedin. He not only immediately apologized about being late to our appointment but gave the reason why. He explained his attention to his patients is his priority. He was extremely personable and professional and took his time to make sure all our questions were answered.
    Decorative Caduceus

    An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA...

    Blinded Independent Review Committee (BIRC) assessed Metastasis Free Survival (MFS) is defined as the time from randomization to first evidence of radiographically detectable bone or soft tissue distant metastasis by conventional ...

    Recruiting

    Decorative Caduceus

    Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intens...

    Recruiting

    Decorative Caduceus

    Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy...

    Kaplan-Meier curves will be generated and metastasis-free survival compared between the two treatment groups by a logrank test, stratified by prostate specific antigen (PSA) level after prostatectomy (never detectable or rising). ...

    Recruiting

    Share